Is Fennec Pharmaceuticals Inc. (FENC) a Buy, Sell, or Hold?
NASDAQ : FENC
Fennec Pharmaceuticals Inc. — Insider Trades
$11.575 USD
$0.73 (6.78%)
- Volume
- 226.65K
- Average Volume
- 265.12K
- Market Capitalization
- $402.08M
- P/E Ratio
- -37.69
- Dividend Yield
- 0.00%
- Price Target
- $16.00
- Year High
- $11.66
- Year Low
- $5.65
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.98
Insider Activity Summary (Last 12 Months)
Insiders Buying
77
Insiders Selling
36
Amount of Insider Selling
$1.64M
FENC Insider Buying/Selling by Quarter
FENC Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Raykov Rosty | other: Former Director | 2026-08-03 | S-Sale | 9.58 | 2026-08-04 |
| Sayad Pierre Sargis | officer: Chief Medical Officer | 2026-07-31 | A-Award | 0 | 2026-08-03 |
| Evans Terry L | officer: Chief Commercial Officer | 2026-07-31 | A-Award | 0 | 2026-08-03 |
| Cioffi Christiana Marie | officer: Chief Strategy Officer | 2026-07-31 | A-Award | 0 | 2026-08-03 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | 2026-07-31 | A-Award | 0 | 2026-08-03 |
| Raykov Rosty | other: Former Director | 2026-07-31 | A-Award | 0 | 2026-08-03 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-07-31 | A-Award | 0 | 2026-08-03 |
| Raykov Rosty | other: Former Director | 2026-07-01 | M-Exempt | 2.45 | 2026-07-02 |
| Raykov Rosty | other: Former Director | 2026-07-01 | M-Exempt | 2.45 | 2026-07-02 |
| Raykov Rosty | other: Former Director | 2026-07-01 | S-Sale | 10.41 | 2026-07-02 |
| Raykov Rosty | other: Former Director | 2026-07-01 | A-Award | 0 | 2026-07-02 |
| Evans Terry L | officer: Chief Commercial Officer | 2026-06-30 | A-Award | 0 | 2026-07-01 |
| Sayad Pierre Sargis | officer: Chief Medical Officer | 2026-06-30 | A-Award | 0 | 2026-07-01 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | 2026-06-30 | A-Award | 0 | 2026-07-01 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-06-30 | A-Award | 0 | 2026-07-01 |
| Cioffi Christiana Marie | officer: Chief Strategy Officer | 2026-06-30 | A-Award | 0 | 2026-07-01 |
| Brughera Marco Maria | director | 2026-06-10 | A-Award | 8.7 | 2026-06-10 |
| Cook Jodi A | director | 2026-06-10 | A-Award | 8.7 | 2026-06-10 |
| Islam Khalid | director | 2026-06-10 | A-Award | 8.7 | 2026-06-10 |
| RALLIS CHRIS A | director | 2026-06-10 | A-Award | 8.7 | 2026-06-10 |
| Raykov Rosty | director | 2026-06-01 | M-Exempt | 2.45 | 2026-06-02 |
| Raykov Rosty | director | 2026-06-01 | M-Exempt | 2.45 | 2026-06-02 |
| Raykov Rosty | director | 2026-06-01 | S-Sale | 9.62 | 2026-06-02 |
| Raykov Rosty | director | 2026-05-31 | A-Award | 0 | 2026-06-02 |
| Cioffi Christiana Marie | officer: Chief Strategy Officer | 2026-05-31 | A-Award | 0 | 2026-06-01 |
| Evans Terry L | officer: Chief Commercial Officer | 2026-05-31 | A-Award | 0 | 2026-06-01 |
| Sayad Pierre Sargis | officer: Chief Medical Officer | 2026-05-31 | A-Award | 0 | 2026-06-01 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | 2026-05-31 | A-Award | 0 | 2026-06-01 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-05-31 | A-Award | 0 | 2026-06-01 |
| RALLIS CHRIS A | director | 2026-05-11 | M-Exempt | 2.44 | 2026-05-12 |
| RALLIS CHRIS A | director | 2026-05-11 | M-Exempt | 2.44 | 2026-05-12 |
| RALLIS CHRIS A | director | 2026-05-11 | S-Sale | 7.04 | 2026-05-12 |
| Raykov Rosty | director | 2026-05-01 | M-Exempt | 2.45 | 2026-05-01 |
| Raykov Rosty | director | 2026-05-01 | M-Exempt | 2.45 | 2026-05-01 |
| Raykov Rosty | director | 2026-05-01 | S-Sale | 6.47 | 2026-05-01 |
| Raykov Rosty | director | 2026-04-30 | M-Exempt | 0 | 2026-05-01 |
| Evans Terry L | officer: Chief Commercial Officer | 2026-04-30 | M-Exempt | 0 | 2026-05-01 |
| Cioffi Christiana Marie | officer: Chief Strategy Officer | 2026-04-30 | M-Exempt | 0 | 2026-05-01 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | 2026-04-30 | M-Exempt | 0 | 2026-05-01 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-04-30 | M-Exempt | 0 | 2026-05-01 |
| Sayad Pierre Sargis | officer: Chief Medical Officer | 2026-04-30 | M-Exempt | 0 | 2026-05-01 |
| Cioffi Christiana Marie | officer: Chief Strategy Officer | 2026-03-31 | A-Award | 5.77 | 2026-04-02 |
| Cioffi Christiana Marie | officer: Chief Strategy Officer | 2026-03-28 | M-Exempt | 0 | 2026-04-02 |
| Cioffi Christiana Marie | officer: Chief Strategy Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Cioffi Christiana Marie | officer: Chief Strategy Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | 2026-03-31 | A-Award | 5.77 | 2026-04-02 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | 2026-03-28 | M-Exempt | 0 | 2026-04-02 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Raykov Rosty | director | 2026-04-01 | M-Exempt | 2.45 | 2026-04-02 |
| Raykov Rosty | director | 2026-04-01 | M-Exempt | 2.45 | 2026-04-02 |
| Raykov Rosty | director | 2026-04-01 | S-Sale | 6.31 | 2026-04-02 |
| Raykov Rosty | director | 2026-03-31 | A-Award | 0 | 2026-04-02 |
| Sayad Pierre Sargis | officer: Chief Medical Officer | 2026-03-31 | A-Award | 5.77 | 2026-04-02 |
| Sayad Pierre Sargis | officer: Chief Medical Officer | 2026-03-28 | M-Exempt | 0 | 2026-04-02 |
| Sayad Pierre Sargis | officer: Chief Medical Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Sayad Pierre Sargis | officer: Chief Medical Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-03-31 | A-Award | 5.77 | 2026-04-02 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-03-28 | M-Exempt | 0 | 2026-04-02 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Evans Terry L | officer: Chief Commercial Officer | 2026-03-31 | A-Award | 5.77 | 2026-04-02 |
| Evans Terry L | officer: Chief Commercial Officer | 2026-03-28 | M-Exempt | 0 | 2026-04-02 |
| Evans Terry L | officer: Chief Commercial Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Evans Terry L | officer: Chief Commercial Officer | 2026-03-31 | M-Exempt | 0 | 2026-04-02 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-03-26 | M-Exempt | 5.1 | 2026-03-26 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-03-26 | M-Exempt | 5.1 | 2026-03-26 |
| Cioffi Christiana Marie | officer: Chief Strategy Officer | 2026-03-26 | M-Exempt | 4.23 | 2026-03-26 |
| Cioffi Christiana Marie | officer: Chief Strategy Officer | 2026-03-26 | M-Exempt | 4.23 | 2026-03-26 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-02-28 | A-Award | 0 | 2026-03-03 |
| Raykov Rosty | director | 2026-03-02 | M-Exempt | 2.45 | 2026-03-03 |
| Raykov Rosty | director | 2026-03-02 | M-Exempt | 2.45 | 2026-03-03 |
| Raykov Rosty | director | 2026-02-28 | A-Award | 0 | 2026-03-03 |
| Raykov Rosty | director | 2026-03-02 | S-Sale | 8.36 | 2026-03-03 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | 2026-02-18 | M-Exempt | 0 | 2026-02-19 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-02-18 | M-Exempt | 4.08 | 2026-02-19 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-02-18 | M-Exempt | 0 | 2026-02-19 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-02-18 | M-Exempt | 4.08 | 2026-02-19 |
| Raykov Rosty | director | 2026-02-02 | M-Exempt | 2.45 | 2026-02-02 |
| Raykov Rosty | director | 2026-02-02 | M-Exempt | 2.45 | 2026-02-02 |
| Raykov Rosty | director | 2026-02-02 | S-Sale | 7.76 | 2026-02-02 |
| Raykov Rosty | director | 2026-01-31 | A-Award | 0 | 2026-02-02 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-01-31 | A-Award | 0 | 2026-02-02 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-01-23 | M-Exempt | 2.45 | 2026-01-23 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-01-23 | M-Exempt | 2.45 | 2026-01-23 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-01-15 | M-Exempt | 2.45 | 2026-01-15 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-01-15 | M-Exempt | 2.45 | 2026-01-15 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-01-07 | M-Exempt | 2.45 | 2026-01-07 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2026-01-07 | M-Exempt | 2.45 | 2026-01-07 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2025-12-31 | A-Award | 0 | 2026-01-05 |
| Raykov Rosty | director | 2026-01-02 | M-Exempt | 2.45 | 2026-01-05 |
| Raykov Rosty | director | 2026-01-02 | M-Exempt | 2.45 | 2026-01-05 |
| Raykov Rosty | director | 2026-01-02 | S-Sale | 7.6 | 2026-01-05 |
| Raykov Rosty | director | 2025-12-31 | A-Award | 0 | 2026-01-05 |
| Southpoint Capital Advisors LP | 10 percent owner | 2025-12-24 | S-Sale | 7.5 | 2025-12-29 |
| Raykov Rosty | director | 2025-12-05 | S-Sale | 7.54 | 2025-12-05 |
| Andrade Robert | officer: CHIEF FINANCIAL OFFICER | 2025-12-01 | A-Award | 0 | 2025-12-02 |
| Raykov Rosty | director | 2025-12-01 | A-Award | 0 | 2025-12-02 |
| Southpoint Capital Advisors LP | 10 percent owner | 2025-11-18 | S-Sale | 8.7921 | 2025-11-20 |
| Southpoint Capital Advisors LP | 10 percent owner | 2025-11-14 | S-Sale | 7.9977 | 2025-11-17 |